Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-051170

Chief Medical Officer sold 12,500 shares at an average $31.90 ($398,694)

  • Chief Medical Officer acquired 12,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Pang Phillip · Chief Medical Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2020-09-16 Exercise or conversion : show line 1 in the form +9,720 $1.58 $15,309 39,497 D
2020-09-16 Exercise or conversion : show line 2 in the form +465 $1.53 $711 39,962 D
2020-09-16 Exercise or conversion : show line 3 in the form +2,315 $5.18 $11,980 42,277 D
2020-09-16 Sale : show line 4 in the form −7,500 $31.88 $239,103 34,777 D
2020-09-16 Sale : show line 5 in the form −5,000 $31.92 $159,591 29,777 D
Open-market sales · 12,500 sh · avg $31.90 · $398,694

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2020-09-16 Exercise or conversion : show line 6 in the form Employee Stock Option (Right to Buy) −9,720 53,242 D
2020-09-16 Exercise or conversion : show line 7 in the form Employee Stock Option (Right to Buy) −465 110,646 D
2020-09-16 Exercise or conversion : show line 8 in the form Employee Stock Option (Right to Buy) −2,315 69,444 D
Loading xslF345X03/doc4.xml…